Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Seawolf Therapeutics

Request full access

Redosable, non-viral DNA medicines for chronic diseases.

San Diego, United StatesFounded 2021Biotech & Life Sciences

About Seawolf Therapeutics

Seawolf Therapeutics is a San Diego-based biotechnology company that launched in November 2026 after operating in stealth since 2021. The company was founded by CEO Elizabeth Alcamo, Ph.D., a former entrepreneur in residence for Versant Ventures with previous senior roles at CODA Biotherapeutics and 4D Molecular Therapeutics. Seawolf emerged with $100 million in financing from a seed round led by founding investor Versant Ventures, and a Series A round with backing from major players including MPM BioImpact, Novartis Venture Fund, Eli Lilly and Company, and CRISPR Therapeutics AG.

The company focuses on developing next-generation, non-viral DNA medicines. Its core technology is the TRIDENT™ platform, a redosable lipid nanoparticle (LNP)-based system designed to deliver DNA payloads into the cell's nucleus. This proprietary system aims to provide the long-term, stable expression of therapeutic proteins, overcoming the short-lived effects of RNA-based therapies while avoiding the immunogenicity and one-time-dosing limitations of viral-based gene therapies. The TRIDENT platform consists of a specialized LNP carrying an immune-quiet DNA and an auxiliary factor that helps it enter the nucleus, enabling durable and potent therapeutic effects that have been demonstrated in primate models.

Seawolf's business model combines in-house drug development with strategic partnerships. The company's lead proprietary program is advancing a candidate to address metabolic diseases, with preclinical models showing potential for treating obesity, muscle loss (sarcopenia), and osteoporosis. Concurrently with its public launch, Seawolf announced a multi-target research collaboration and exclusive license agreement with Sanofi. This partnership, valued at up to $1.2 billion in potential milestones plus royalties, is focused on developing therapies for bleeding disorders and other undisclosed indications.

Source: Dealroom company data

At a glance

Status
Operational
Employees
26
Open positions
None listed
Industry
Health
Sub-industry
BioTechnology
Sector
Gene Therapy, Chronic Disease, Drug Development
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Nov 2026 $100M $600M Versant Ventures · Alexandria Venture Investments · CRISPR Therapeutics · Eli Lilly ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Seawolf Therapeutics in the San Diego ecosystem

Live from Dealroom

The Seawolf Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Versant Ventures
  • Alexandria Venture Investments
  • CRISPR Therapeutics
  • Eli Lilly
  • MPM BioImpact
  • Novartis Venture Fund
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Diego HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Seawolf Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Seawolf Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.